X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
65
PharmaCompass offers a list of Clobetasol Propionate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clobetasol Propionate manufacturer or Clobetasol Propionate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clobetasol Propionate manufacturer or Clobetasol Propionate supplier.
PharmaCompass also assists you with knowing the Clobetasol Propionate API Price utilized in the formulation of products. Clobetasol Propionate API Price is not always fixed or binding as the Clobetasol Propionate Price is obtained through a variety of data sources. The Clobetasol Propionate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clobetasol Propionate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clobetasol Propionate, including repackagers and relabelers. The FDA regulates Clobetasol Propionate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clobetasol Propionate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clobetasol Propionate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clobetasol Propionate supplier is an individual or a company that provides Clobetasol Propionate active pharmaceutical ingredient (API) or Clobetasol Propionate finished formulations upon request. The Clobetasol Propionate suppliers may include Clobetasol Propionate API manufacturers, exporters, distributors and traders.
click here to find a list of Clobetasol Propionate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clobetasol Propionate DMF (Drug Master File) is a document detailing the whole manufacturing process of Clobetasol Propionate active pharmaceutical ingredient (API) in detail. Different forms of Clobetasol Propionate DMFs exist exist since differing nations have different regulations, such as Clobetasol Propionate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clobetasol Propionate DMF submitted to regulatory agencies in the US is known as a USDMF. Clobetasol Propionate USDMF includes data on Clobetasol Propionate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clobetasol Propionate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clobetasol Propionate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Clobetasol Propionate Drug Master File in Japan (Clobetasol Propionate JDMF) empowers Clobetasol Propionate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Clobetasol Propionate JDMF during the approval evaluation for pharmaceutical products. At the time of Clobetasol Propionate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Clobetasol Propionate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clobetasol Propionate Drug Master File in Korea (Clobetasol Propionate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clobetasol Propionate. The MFDS reviews the Clobetasol Propionate KDMF as part of the drug registration process and uses the information provided in the Clobetasol Propionate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clobetasol Propionate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clobetasol Propionate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clobetasol Propionate suppliers with KDMF on PharmaCompass.
A Clobetasol Propionate CEP of the European Pharmacopoeia monograph is often referred to as a Clobetasol Propionate Certificate of Suitability (COS). The purpose of a Clobetasol Propionate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clobetasol Propionate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clobetasol Propionate to their clients by showing that a Clobetasol Propionate CEP has been issued for it. The manufacturer submits a Clobetasol Propionate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clobetasol Propionate CEP holder for the record. Additionally, the data presented in the Clobetasol Propionate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clobetasol Propionate DMF.
A Clobetasol Propionate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clobetasol Propionate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clobetasol Propionate suppliers with CEP (COS) on PharmaCompass.
A Clobetasol Propionate written confirmation (Clobetasol Propionate WC) is an official document issued by a regulatory agency to a Clobetasol Propionate manufacturer, verifying that the manufacturing facility of a Clobetasol Propionate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clobetasol Propionate APIs or Clobetasol Propionate finished pharmaceutical products to another nation, regulatory agencies frequently require a Clobetasol Propionate WC (written confirmation) as part of the regulatory process.
click here to find a list of Clobetasol Propionate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clobetasol Propionate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clobetasol Propionate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clobetasol Propionate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clobetasol Propionate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clobetasol Propionate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clobetasol Propionate suppliers with NDC on PharmaCompass.
Clobetasol Propionate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clobetasol Propionate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clobetasol Propionate GMP manufacturer or Clobetasol Propionate GMP API supplier for your needs.
A Clobetasol Propionate CoA (Certificate of Analysis) is a formal document that attests to Clobetasol Propionate's compliance with Clobetasol Propionate specifications and serves as a tool for batch-level quality control.
Clobetasol Propionate CoA mostly includes findings from lab analyses of a specific batch. For each Clobetasol Propionate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clobetasol Propionate may be tested according to a variety of international standards, such as European Pharmacopoeia (Clobetasol Propionate EP), Clobetasol Propionate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clobetasol Propionate USP).
Market Place
